Monday - Friday, 6:00 - 7:00 PM ET
CNBC’s Jim Cramer reviewed Medline
, a medical supplies giant that made its market debut Wednesday, saying that he’d wait for a pullback to buy the stock after shares soared more than 41%.
“We had the largest IPO in over four years today, and it generally went pretty darn well,” Cramer said. “In fact, it went so well that Medline looks a little too expensive for me.”
Medline was the biggest IPO of the year globally. The company managed to raise $6.26 billion, and the stock opened up $35, up from its initial pricing of $29.
